1. Home
  2. EVGN vs PMAX Comparison

EVGN vs PMAX Comparison

Compare EVGN & PMAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EVGN
  • PMAX
  • Stock Information
  • Founded
  • EVGN 1999
  • PMAX 2019
  • Country
  • EVGN Israel
  • PMAX Hong Kong
  • Employees
  • EVGN 75
  • PMAX N/A
  • Industry
  • EVGN Agricultural Chemicals
  • PMAX
  • Sector
  • EVGN Industrials
  • PMAX
  • Exchange
  • EVGN Nasdaq
  • PMAX Nasdaq
  • Market Cap
  • EVGN 11.3M
  • PMAX 7.9M
  • IPO Year
  • EVGN N/A
  • PMAX 2024
  • Fundamental
  • Price
  • EVGN $1.33
  • PMAX $0.50
  • Analyst Decision
  • EVGN Strong Buy
  • PMAX
  • Analyst Count
  • EVGN 1
  • PMAX 0
  • Target Price
  • EVGN $3.50
  • PMAX N/A
  • AVG Volume (30 Days)
  • EVGN 5.5M
  • PMAX 1.5M
  • Earning Date
  • EVGN 08-21-2025
  • PMAX 04-28-2025
  • Dividend Yield
  • EVGN N/A
  • PMAX N/A
  • EPS Growth
  • EVGN N/A
  • PMAX N/A
  • EPS
  • EVGN N/A
  • PMAX N/A
  • Revenue
  • EVGN $6,765,000.00
  • PMAX $4,694,079.00
  • Revenue This Year
  • EVGN N/A
  • PMAX N/A
  • Revenue Next Year
  • EVGN $113.18
  • PMAX N/A
  • P/E Ratio
  • EVGN N/A
  • PMAX N/A
  • Revenue Growth
  • EVGN N/A
  • PMAX N/A
  • 52 Week Low
  • EVGN $0.95
  • PMAX $0.28
  • 52 Week High
  • EVGN $6.80
  • PMAX $4.70
  • Technical
  • Relative Strength Index (RSI)
  • EVGN 49.73
  • PMAX N/A
  • Support Level
  • EVGN $1.26
  • PMAX N/A
  • Resistance Level
  • EVGN $1.44
  • PMAX N/A
  • Average True Range (ATR)
  • EVGN 0.11
  • PMAX 0.00
  • MACD
  • EVGN -0.02
  • PMAX 0.00
  • Stochastic Oscillator
  • EVGN 21.62
  • PMAX 0.00

About EVGN Evogene Ltd

Evogene Ltd is a computational biology company targeting to revolutionize product development for life-science based industries, including human health, agriculture, and industrial applications. The company established its technology, the Computational Predictive Biology (CPB) platform. The CPB platform is designed to computationally discover and develop life-science products based on microbes, small molecules, and genetic elements as the core components for such products. It holds several subsidiaries utilizing the CPB platform for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits, and ag-solutions for castor oil production. It generates maximum revenue from the Agriculture segment, followed by Industry.

About PMAX Powell Max Limited Class A Ordinary Shares

Powell Max Ltd is an financial communications services provider. Its financial communications services cover a full range of financial printing, corporate reporting, communications and language support services from inception to completion, including typesetting, proofreading, translation, design, printing, electronic reporting, newspaper placement and distribution. It operates in a single business segment which is the provision of corporate financial communications and financial printing services. All operations are carried in Hong Kong.

Share on Social Networks: